These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2103150)

  • 1. 1,000 renal transplants at the Massachusetts General Hospital: improved allograft survival for high-risk patients without regard to HLA matching.
    Delmonico FL; Fuller TC; Cosimi AB
    Clin Transpl; 1990; ():247-53. PubMed ID: 2103150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
    Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kidney transplant program at the Massachusetts general hospital.
    Pascual M; Tolkoff-Rubin N; Farrell ML; Williams W; Auchincloss H; Ko D; Saidman S; Colvin RB; Cosimi AB; Delmonico FL
    Clin Transpl; 2001; ():123-30. PubMed ID: 12211774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
    Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
    Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 10. The fate of renal transplants in patients with IgA nephropathy.
    Frohnert PP; Donadio JV; Velosa JA; Holley KE; Sterioff S
    Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of HLA mismatch on highly sensitized renal allograft recipients.
    Paramesh AS; Zhang R; Baber J; Yau CL; Slakey DP; Killackey MT; Ren Q; Sullivan K; Heneghan J; Florman SS
    Clin Transplant; 2010; 24(6):E247-52. PubMed ID: 20682021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of race and ethnicity on kidney allograft outcome.
    Katznelson S; Gjertson DW; Cecka JM
    Clin Transpl; 1995; ():379-94. PubMed ID: 8794281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive regimens and their effects on renal allograft outcome.
    Katznelson S; Cecka JM
    Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal transplantation in highly sensitized patients: five years of the SOS Scheme.
    Klouda PT; Corbin SA; Ray TC; Rogers CA; Bradley BA
    Clin Transpl; 1990; ():69-73. PubMed ID: 2103180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients.
    Valentini RP; Nehlsen-Cannarella SL; Gruber SA; Mattoo TK; West MS; Lang C; Imam AA
    Pediatr Transplant; 2007 Feb; 11(1):77-81. PubMed ID: 17239127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
    Shield CF
    Clin Transpl; 1990; ():265-74. PubMed ID: 2129408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One thousand renal transplants in Belfast (1968-1998).
    Middleton D; Douglas JF; Opelz G; Doehler B; McGeown MG
    Clin Transpl; 2004; ():151-64. PubMed ID: 16704148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HLA-matching effect in different cohorts of kidney transplant recipients.
    Terasaki PI
    Clin Transpl; 2000; ():497-514. PubMed ID: 11512361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.